Empresa Curative Biotechnology, Inc. Other OTC
Acciones
CTYX
US20786Q2093
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
I. Garr
CEO | Chief Executive Officer | 71 | 11/02/21 |
Paul M. Michael
CHM | Chairman | - | - |
Steve Chizzik
IRC | Investor Relations Contact | - | - |
Ron Bordens
PRN | Corporate Officer/Principal | - | 11/02/21 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Cary Sucoff
BRD | Director/Board Member | 71 | 12/05/22 |
Theresa Heah
BRD | Director/Board Member | 46 | 31/03 |
Lawrence Zaslow
BRD | Director/Board Member | - | - |
Paul M. Michael
CHM | Chairman | - | - |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 0 | 227 000 | 0 | 0 | 99,94 % |
Acción B | 1 | 903 263 385 | 902 756 978 ( 99,94 %) | 0 | |
Acción C | 0 | 30 000 000 | 0 | 0 |
Información de la empresa
Curative Biotechnology, Inc.
3801 PGA Boulevard Suite 600
33410, Palm Beach Gardens
+
http://www.curativebiotech.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
+44,48 % | 54,04 mil M | |
+43,57 % | 41,96 mil M | |
-0,86 % | 41,92 mil M | |
-7,59 % | 28,35 mil M | |
+12,30 % | 26,35 mil M | |
-21,83 % | 19 mil M | |
+7,15 % | 13 mil M | |
+29,40 % | 12,28 mil M | |
+25,15 % | 12,19 mil M |